Zimmer Biomet’s revenue in the first quarter of 2025 was mostly flat with a 1.1% increase year-over-year, according to financial results posted May 5.
Five things to know:
1. Quarterly sales reached $1.9 billion, and Zimmer Biomet’s net earnings were $182 million.
2. Hip and knee sales saw year-over-year growth of less than 1%. Knee sales were $792.9 million, and hips were $495.8 million.
3. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales rose 3.9% year over year to $470.5 million.
4. U.S. sales saw more year-over-year growth (1.3%) compared to international sales (0.7%).
5. Zimmer Biomet projects its full-year revenue to increase 5.7% to 8.2%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
